These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3311551)

  • 1. Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol.
    Kandrotas RJ; Slaughter RL; Brass C; Jusko WJ
    Clin Pharmacol Ther; 1987 Oct; 42(4):465-70. PubMed ID: 3311551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion.
    Glynn AM; Slaughter RL; Brass C; D'Ambrosio R; Jusko WJ
    Clin Pharmacol Ther; 1986 Jun; 39(6):654-9. PubMed ID: 3709030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H
    Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma.
    Kong AN; Slaughter RL; Jusko WJ
    J Chromatogr; 1988 Nov; 432():308-14. PubMed ID: 3065346
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Kong AN; Ludwig EA; Slaughter RL; DiStefano PM; DeMasi J; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):616-28. PubMed ID: 2689044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.
    Dunn TE; Ludwig EA; Slaughter RL; Camara DS; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):536-49. PubMed ID: 1827621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination.
    Ludwig EA; Slaughter RL; Savliwala M; Brass C; Jusko WJ
    DICP; 1989 Nov; 23(11):858-61. PubMed ID: 2596127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.
    Tornatore KM; Venuto RC; Logue G; Davis PJ
    J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy.
    Osoba D; Erlichman C; Willan AR; Brigden ML; Geggie P; Pater JL; Rusthoven JJ; Wilson KS
    Clin Invest Med; 1988 Oct; 11(5):377-9. PubMed ID: 3052974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers.
    Ferry JJ; Della-Coletta AA; Weber DJ; VanderLugt JT
    J Clin Pharmacol; 1994 Nov; 34(11):1109-15. PubMed ID: 7876403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
    Parker TJ; Daley-Yates PT; Wood SA
    Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis.
    Ebling WF; Szefler SJ; Jusko WJ
    J Chromatogr; 1984 Feb; 305(2):271-80. PubMed ID: 6368578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methylprednisolone succinate, methylprednisolone, and lidocaine in the normal dog and during hemorrhagic shock.
    Toutain PL; Autefage A; Oukessou M; Alvinerie M
    J Pharm Sci; 1987 Jul; 76(7):528-34. PubMed ID: 3312572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous methylprednisolone in adults in status asthmaticus. Comparison of two dosages.
    Tanaka RM; Santiago SM; Kuhn GJ; Williams RE; Klaustermeyer WB
    Chest; 1982 Oct; 82(4):438-40. PubMed ID: 6749443
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone.
    Yamashita SK; Ludwig EA; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):558-70. PubMed ID: 1827622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.